Effects of Non-Steroidal Mineralocorticoid Antagonist (Finerenone) in Western Diet-Induced Kidney Disease

被引:0
|
作者
Myakala, Komuraiah [1 ]
Ribeiro, Patricia de Carvalho [1 ]
Wang, Xiaoxin [1 ]
Korolowicz, Kyle E. [1 ]
Rodriguez, Olga C. [1 ]
Albanese, Chris [1 ]
Levi, Moshe [1 ]
机构
[1] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
SA-PO242
引用
收藏
页码:668 / 668
页数:1
相关论文
共 50 条
  • [21] Benefits of the Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone in Metabolic Syndrome-Related Heart Failure with Preserved Ejection Fraction
    Lima-Posada, Ixchel
    Stephan, Yohan
    Soulie, Matthieu
    Palacios-Ramirez, Roberto
    Bonnard, Benjamin
    Nicol, Lionel
    Kolkhof, Peter
    Jaisser, Frederic
    Mulder, Paul
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [22] Finerenone: Questions and Answers-The Four Fundamental Arguments on the New-Born Promising Non-Steroidal Mineralocorticoid Receptor Antagonist
    Di Lullo, Luca
    Lavalle, Carlo
    Scatena, Alessia
    Mariani, Marco Valerio
    Ronco, Claudio
    Bellasi, Antonio
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (12)
  • [23] Non-steroidal mineralocorticoid receptor antagonist, finerenone, attenuates obesity- and hypertension-induced cardiomyocyte hypertrophy in a blood pressure-independent manner
    Morikawa, K.
    Arima, Y.
    Fujiyama, A.
    Yamada, T.
    Hanatani, S.
    Yamamoto, E.
    Tsujita, K.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [24] SUPPRESSION OF MOUSE CRESCENTIC GLOMERULONEPHRITIS WITH A NON-STEROIDAL MINERALOCORTICOID RECEPTOR ANTAGONIST
    Tesch, G. H.
    Han, Y.
    Ma, F.
    Nikolic-Paterson, D. J.
    Kolkhof, P.
    NEPHROLOGY, 2015, 20 : 33 - 34
  • [25] Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease
    Pandey, Arjun K.
    Bhatt, Deepak L.
    Cosentino, Francesco
    Marx, Nikolaus
    Rotstein, Ori
    Pitt, Bertram
    Pandey, Ambirash
    Butler, Javed
    Verma, Subodh
    EUROPEAN HEART JOURNAL, 2022, 43 (31) : 2931 - 2945
  • [26] The use of a novel non-steroidal mineralocorticoid receptor antagonist finerenone for the treatment of chronic heart failure A systematic review and meta-analysis
    Pei, Hui
    Wang, Wei
    Zhao, Di
    Wang, Lei
    Su, Guo-Hai
    Zhao, Zhuo
    MEDICINE, 2018, 97 (16)
  • [27] The novel mineralocorticoid receptor antagonist finerenone in diabetic kidney disease: Progress and challenges
    Yang, Pingping
    Huang, Tianlun
    Xu, Gaosi
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (09): : 1342 - 1349
  • [28] Effects of Finerenone, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, on Cardiovascular Disease, Chronic Kidney Disease, and Blood Pressure
    Jonathan D. Ravid
    Luke J. Laffin
    Current Cardiology Reports, 2022, 24 : 1251 - 1259
  • [29] Effects of Finerenone, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, on Cardiovascular Disease, Chronic Kidney Disease, and Blood Pressure
    Ravid, Jonathan D.
    Laffin, Luke J.
    CURRENT CARDIOLOGY REPORTS, 2022, 24 (10) : 1251 - 1259
  • [30] Discovery of AZD9977: A non-steroidal mineralocorticoid modulator for treatment of diabetic kidney disease
    Granberg, Kenneth
    Yuan, Zhong-Qing
    Lindmark, Bo
    Edman, Karl
    Bamberg, Krister
    Hogner, Anders
    Kajanus, Johan
    Malmgren, Marcus
    Lofberg, Christian
    Nordqvist, Anneli
    Lindberg, Jan
    Branalt, Jonas
    OMahony, Gavin
    Kossenjans, Michael
    Liu, Dongmei
    Aagaard, Anna
    Billger, Martin
    Backstrom, Stefan
    Cornwall, Philip
    Ericsson, Hans
    Erlandsson, Fredrik
    Hansson, Eva
    Hayen, Ahlke
    Hermansson, Majlis
    Ivarsson, Ida
    Lofmark, Rasmus Jansson
    Johansson, Ulrika
    Karlsson, Ulla
    Li, Xueqing
    Nikitidis, Grigorios
    Nordberg, Peter
    Nordin, Andreas
    Polentarutti, Britta
    Selmi, Nidhal
    Turner, Andrew
    William-Olsson, Lena
    Wingolf, Caroline
    Hartleib, Judith
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253